Advantages of paramagnetic chemical exchange saturation transfer (CEST) complexes having slow to intermediate water exchange properties as responsive MRI agents

Paramagnetic chemical exchange saturation transfer (PARACEST) complexes are exogenous contrast agents that have great potential to further extend the functional and molecular imaging capabilities of magnetic resonance. As a result of the presence of a central paramagnetic lanthanide ion (Ln3+ ≠ La3+, Gd3+, Lu3+) within the chelate, the resonance frequencies of exchangeable protons bound to the PARACEST agent are shifted far away from the bulk water frequency. This large chemical shift, combined with an extreme sensitivity to the chemical exchange rate, make PARACEST agents ideally suited for the reporting of significant biological metrics, such as temperature, pH and the presence of metabolites. In addition, the ability to turn PARACEST agents ‘off’ and ‘on’ using a frequency‐selective saturation pulse gives them a distinct advantage over Gd3+‐based contrast agents. A current challenge for PARACEST research is the translation of the promising in vitro results into in vivo systems. This short review article first describes the basic theory behind PARACEST contrast agents, their benefits over other contrast agents and their applications to MRI. It then describes some of the recent PARACEST research results: specifically, pH measurements using water molecule exchange rate modulation, T2 exchange contrast caused by water molecule exchange, the use of ultrashort TEs (TE < 10 µs) to overcome T2 exchange line broadening and the potential application of T2 exchange as a new contrast mechanism for MRI. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  O. Togao,et al.  SWIFT‐CEST: A new MRI method to overcome T2 shortening caused by PARACEST contrast agents , 2012, Magnetic resonance in medicine.

[2]  A. Sherry,et al.  T2 exchange agents: A new class of paramagnetic MRI contrast agent that shortens water T2 by chemical exchange rather than relaxation , 2011, Magnetic resonance in medicine.

[3]  J. Morrow,et al.  Iron(II) PARACEST MRI contrast agents. , 2011, Journal of the American Chemical Society.

[4]  A. Sherry,et al.  A responsive europium(III) chelate that provides a direct readout of pH by MRI. , 2010, Journal of the American Chemical Society.

[5]  Zoltan Kovacs,et al.  Alternatives to gadolinium-based metal chelates for magnetic resonance imaging. , 2010, Chemical reviews.

[6]  Ravi S. Menon,et al.  In Vivo Detection of PARACEST Agents With Relaxation Correction , 2010, Magnetic resonance in medicine.

[7]  Ileana Hancu,et al.  A concentration‐independent method to measure exchange rates in PARACEST agents , 2010, Magnetic resonance in medicine.

[8]  A. Sherry,et al.  Multi-frequency PARACEST agents based on europium(III)-DOTA-tetraamide ligands. , 2009, Angewandte Chemie.

[9]  J. Morrow,et al.  A PARACEST agent responsive to inner- and outer-sphere phosphate ester interactions for MRI applications. , 2009, Journal of the American Chemical Society.

[10]  A. Sherry,et al.  Imaging the tissue distribution of glucose in livers using a PARACEST sensor , 2008, Magnetic resonance in medicine.

[11]  M. Woods,et al.  Polymeric PARACEST agents for enhancing MRI contrast sensitivity. , 2008, Journal of the American Chemical Society.

[12]  A. Sherry,et al.  Modulation of water exchange in europium(III) DOTA-tetraamide complexes via electronic substituent effects. , 2008, Journal of the American Chemical Society.

[13]  Yuguo Li,et al.  Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide , 2007, Magnetic resonance in medicine.

[14]  E. Terreno,et al.  Gd-loaded liposomes as T1, susceptibility, and CEST agents, all in one. , 2007, Journal of the American Chemical Society.

[15]  Byunghee Yoo,et al.  A PARACEST MRI contrast agent to detect enzyme activity. , 2006, Journal of the American Chemical Society.

[16]  Michael Garwood,et al.  Fast and quiet MRI using a swept radiofrequency. , 2006, Journal of magnetic resonance.

[17]  A Dean Sherry,et al.  Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. , 2006, Chemical Society reviews.

[18]  Craig R Malloy,et al.  MRI thermometry based on PARACEST agents. , 2005, Journal of the American Chemical Society.

[19]  A Dean Sherry,et al.  Selective sensing of zinc ions with a PARACEST contrast agent. , 2005, Angewandte Chemie.

[20]  Enzo Terreno,et al.  Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.

[21]  Enzo Terreno,et al.  Iopamidol: Exploring the potential use of a well‐established x‐ray contrast agent for MRI , 2005, Magnetic resonance in medicine.

[22]  Matthew E Merritt,et al.  Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI , 2005, Magnetic resonance in medicine.

[23]  Enzo Terreno,et al.  Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.

[24]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[25]  A. Sherry,et al.  Toward the Design of MR Agents for Imaging β-Cell Function. , 2004, Current medicinal chemistry. Immunology, endocrine & metabolic agents.

[26]  A Dean Sherry,et al.  Cyclen-based phenylboronate ligands and their Eu3+ complexes for sensing glucose by MRI. , 2004, Bioconjugate chemistry.

[27]  Enzo Terreno,et al.  Ln(III)-DOTAMGly Complexes: A Versatile Series to Assess the Determinants of the Efficacy of Paramagnetic Chemical Exchange Saturation Transfer Agents for Magnetic Resonance Imaging Applications , 2004, Investigative radiology.

[28]  A Dean Sherry,et al.  A paramagnetic CEST agent for imaging glucose by MRI. , 2003, Journal of the American Chemical Society.

[29]  D. Tozer,et al.  Correlation of optical and NMR spectral information with coordination variation for axially symmetric macrocyclic Eu(III) and Yb(III) complexes: axial donor polarisability determines ligand field and cation donor preference , 2003 .

[30]  A. Sherry,et al.  Physical characteristics of lanthanide complexes that act as magnetization transfer (MT) contrast agents , 2003 .

[31]  Enzo Terreno,et al.  Novel pH-reporter MRI contrast agents. , 2002, Angewandte Chemie.

[32]  Enzo Terreno,et al.  A paramagnetic MRI-CEST agent responsive to lactate concentration. , 2002, Journal of the American Chemical Society.

[33]  Enzo Terreno,et al.  Paramagnetic Lanthanide(III) complexes as pH‐sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications , 2002, Magnetic resonance in medicine.

[34]  A. Merbach,et al.  Towards rational design of fast water-exchanging Gd(dota-like) contrast agents? Importance of the M/m ratio. , 2001, Chemistry.

[35]  A. Sherry,et al.  A novel europium(III)-based MRI contrast agent. , 2001, Journal of the American Chemical Society.

[36]  R S Balaban,et al.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.

[37]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[38]  M. Botta,et al.  Water signal suppression by T2‐relaxation enhancement promoted by Dy(III) complexes , 1991 .

[39]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[40]  S. Aime,et al.  A New Class of Contrast Agents for Magnetic Resonance Imaging Based on Selective Reduction of Water‐T2 by Chemical Exchange , 1988, Investigative radiology.

[41]  T. T. Nakashima,et al.  Attenuation of the water resonance in fourier transform 1H NMR spectra of aqueous solutions by spin-spin relaxation , 1985 .

[42]  J. Granot,et al.  Effect of chemical exchange on the transverse relaxation rate of nuclei in solution containing paramagnetic ions , 1974 .

[43]  P. Lauterbur,et al.  Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.

[44]  J. Leigh.  Relaxation times in systems with chemical exchange: Some exact solutions , 1971 .

[45]  R. Damadian.  Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.

[46]  T. J. Swift,et al.  NMR‐Relaxation Mechanisms of O17 in Aqueous Solutions of Paramagnetic Cations and the Lifetime of Water Molecules in the First Coordination Sphere , 1962 .

[47]  Tzu-Chen Yen,et al.  In situ preparation of high relaxivity iron oxide nanoparticles by coating with chitosan: A potential MRI contrast agent useful for cell tracking , 2010 .